# A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

> **NCT06902389** · PHASE1,PHASE2 · RECRUITING · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma (HCC)

## Interventions

- **BIOLOGICAL:** Super Hi-TCR-T cells

## Key facts

- **NCT ID:** NCT06902389
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-04-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902389, "A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06902389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*